Skip to main content

OSTRUM ASSET MANAGEMENT

Position in NBIX — Neurocrine Biosciences Inc

CIK 1767945 PARIS, I0

Position in NBIX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$563,597
+$123,059 QoQ
Shares Held
3,344
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#459
of 768 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

OSTRUM ASSET MANAGEMENT holds $2,914,468 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (19.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NBIX
Neurocrine Biosciences Inc
This page
3,344 $563,597

All Filings in NBIX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $563,597 3,344
2026-03-31 $440,538 3,344
2025-12-31 $613,556 4,326
2025-09-30 $808,448 5,759
2025-06-30 $768,091 6,111
2025-03-31 $695,231 6,286
2024-12-31 $1,529,209 11,203
2024-09-30 $2,263,151 19,642
2024-06-30 $2,671,211 19,403
2024-03-31 $2,884,045 20,911
2023-12-31 $2,755,233 20,911
2023-09-30 $3,277,800 29,136
2023-06-30 $2,461,984 26,108
2023-03-31 $2,640,323 26,085